Abstract
Recently, a large number of peptides and proteins have been utilized as active pharmaceutical ingredients in the clinical field. However, the stability of peptide and protein drugs is often low. In addition, some peptides and proteins adsorb onto glass or polypropylene tube. In the present study, to improve these pharmaceutical properties of peptides and proteins, we newly prepared glucuronylglucosyl-β-cyclodextrin (GUG-β-CyD) conjugate with insulin, a model protein drug, and evaluated its enzymatic or thermal stability and adsorption onto glass or polypropylene tube. The insulin conjugate with GUG-β-CyD was successfully prepared by condensation of amine group of insulin and carboxyl group of GUG-β-CyD. Circular dichroism spectra showed that the secondary structure of insulin in this conjugate was retained. Adsorption of insulin onto glass or polypropylene tube was decreased by the conjugation with GUG-β-CyD. Moreover, enzymatic and thermal stabilities of the conjugate were higher than those of insulin and the mixture of insulin and GUG-β-CyD. These results suggest that insulin conjugation with GUG-β-CyD could improve the pharmaceutical properties of insulin.
Similar content being viewed by others
References
Frokjaer, S., Otzen, D.E.: Protein drug stability: a formulation challenge. Nat. Rev. Drug Discov. 4, 298–306 (2005)
Jadhav, S.B., Singhal, R.S.: Conjugation of α-amylase with dextran for enhanced stability: process details, kinetics and structural analysis. Carbohydr. Polym. 90, 1811–1817 (2012)
Harris, J.M., Chess, R.B.: Effect of pegylation on pharmaceuticals. Nat. Rev. Drug Discov. 2, 214–221 (2003)
Ishihara, H.: Current status and prospects of polyethyleneglycol-modified medicines. Biol. Pharm. Bull. 36, 883–888 (2013)
Nguyen, T.H., Kim, S.H., Decker, C.G., Wong, D.Y., Loo, J.A., Maynard, H.D.: A heparin-mimicking polymer conjugate stabilizes basic fibroblast growth factor. Nat. Chem. 5, 221–227 (2013)
Uekama, K., Hirayama, F., Irie, T.: Cyclodextrin drug carrier systems. Chem. Rev. 98, 2045–2076 (1998)
Irie, T., Uekama, K.: Cyclodextrins in peptide and protein delivery. Adv. Drug Deliv. Rev. 36, 101–123 (1999)
Tavornvipas, S., Hirayama, F., Takeda, S., Arima, H., Uekama, K.: Effects of cyclodextrins on chemically and thermally induced unfolding and aggregation of lysozyme and basic fibroblast growth factor. J. Pharm. Sci. 95, 2722–2729 (2006)
Tavornvipas, S., Tajiri, S., Hirayama, F., Arima, H., Uekama, K.: Effects of hydrophilic cyclodextrins on aggregation of recombinant human growth hormone. Pharm. Res. 21, 2369–2376 (2004)
Tokihiro, K., Irie, T., Hirayama, F., Uekama, K.: Mass spectroscopic evidence on inhibiting effect of maltosyl-β-cyclodextrin on insulin self-association. Pharm. Sci. 2, 519–522 (1996)
Tokihiro, K., Irie, T., Uekama, K.: Potential use of maltosyl-β-cyclodextrin for inhibition of insulin self-association in aqueous solution. Pharm. Sci. 1, 49–53 (1995)
Tokihiro, K., Irie, T., Uekama, K.: Varying effects of cyclodextrin derivatives on aggregation and thermal behavior of insulin in aqueous solution. Chem. Pharm. Bull. 45, 525–531 (1997)
Uehata, K., Anno, T., Hayashida, K., Higashi, T., Motoyama, K., Hirayama, F., Uekama, K., Arima, H.: Peak-less hypoglycemic effect of insulin glargine by complexation with maltosyl-β-cyclodextrin. Int. J. Pharm. 422, 33–39 (2012)
Jono, H., Anno, T., Motoyama, K., Misumi, Y., Tasaki, M., Oshima, T., Mori, Y., Mizuguchi, M., Ueda, M., Shono, M., Obayashi, K., Arima, H., Ando, Y.: Cyclodextrin, a novel therapeutic tool for suppressing amyloidogenic transthyretin misfolding in transthyretin-related amyloidosis. Biochem. J. 437, 35–42 (2011)
Villalonga, R., Fernández, M., Fragoso, A., Cao, R., Pierro, P.D., Mariniello, L., Porta, R.: Transglutaminase-catalyzed synthesis of trypsin-cyclodextrin conjugates: kinetics and stability properties. Biotechnol. Bioeng. 81, 732–737 (2003)
Fernández, M., Villalonga, M.L., Fragoso, A., Cao, R., Baños, M., Villalonga, R.: α-Chymotrypsin stabilization by chemical conjugation with O-carboxymethyl-poly-β-cyclodextrin. Proc. Biochem. 39, 535–539 (2004)
Lee, S., Kim, K., Kumar, T.S., Lee, J., Kim, S.K., Lee, D.Y., Lee, Y.K., Byun, Y.: Synthesis and biological properties of insulin-deoxycholic acid chemical conjugates. Bioconjug. Chem. 16, 615–620 (2005)
Jeffrey, P.D., Milthorpe, B.K., Nichol, L.W.: Polymerization pattern of insulin at pH 7.0. Biochemistry 15, 4660–4665 (1976)
Schilling, R.J., Mitra, A.K.: Degradation of insulin by trypsin and α-chymotrypsin. Pharm. Res. 8, 721–727 (1991)
Acknowledgments
This work was partially supported by a Program for Leading Graduate Schools “HIGO (Health life science: Interdisciplinary and Glocal Oriented) Program”, Kumamoto University, a Grant-in-Aid for Young Scientists (Start-up) from the Ministry of Education, Science and Culture of Japan (23890161) and Kumayaku Rearch Support from KUMAYAKU Alumni Research Foundation.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Hirotsu, T., Higashi, T., Motoyama, K. et al. Improvement of pharmaceutical properties of insulin through conjugation with glucuronylglucosyl-β-cyclodextrin. J Incl Phenom Macrocycl Chem 80, 107–112 (2014). https://doi.org/10.1007/s10847-014-0407-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10847-014-0407-5